Synthesis of carbocyclic pyrimidine nucleosides and their inhibitory activities against Plasmodium falciparum thymidylate kinase. 2013

Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
United Graduate School of Drug Discovery and Medical Information Sciences, Gifu University, 1-1 Yanagido, Gifu 501-1193, Japan.

Plasmodium falciparum thymidylate kinase (PfTMK) is a promising antimalarial target due to its unique substrate specificity. Recently, we reported that 2',3'-dideoxycarbocyclic thymidine showed moderate inhibitory activity and reported the related structure-activity relationship for inhibitors against PfTMK. In this study, we have designed and synthesized enantioselective 2',3'-dideoxycarbocyclic pyrimidine nucleosides based on our previous results and screened them for inhibitory activity against PfTMK. The most potent inhibitor showed K(i)(TMP) and K(i)(dGMP) values of 14 and 20 μM, respectively. The fluorinated dideoxy derivative (-)-7, exhibited lower K(i)(TMP) and higher K(i)(dGMP) compared with that of the parent compound (K(i)(TMP), K(i)(dGMP) equals 20 and 7 μM, respectively). The modification of carbocyclic pyrimidine nucleosides is a promising strategy for developing powerful PfTMK inhibitors.

UI MeSH Term Description Entries
D009703 Nucleoside-Phosphate Kinase An enzyme that catalyzes reversible reactions of a nucleoside triphosphate, e.g., ATP, with a nucleoside monophosphate, e.g., UMP, to form ADP and UDP. Many nucleoside monophosphates can act as acceptor while many ribo- and deoxyribonucleoside triphosphates can act as donor. EC 2.7.4.4. Nucleoside Monophosphate Kinases,Kinase, Nucleoside-Phosphate,Kinases, Nucleoside Monophosphate,Monophosphate Kinases, Nucleoside,Nucleoside Phosphate Kinase
D010963 Plasmodium falciparum A species of protozoa that is the causal agent of falciparum malaria (MALARIA, FALCIPARUM). It is most prevalent in the tropics and subtropics. Plasmodium falciparums,falciparums, Plasmodium
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D000962 Antimalarials Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) Anti-Malarial,Antimalarial,Antimalarial Agent,Antimalarial Drug,Anti-Malarials,Antimalarial Agents,Antimalarial Drugs,Agent, Antimalarial,Agents, Antimalarial,Anti Malarial,Anti Malarials,Drug, Antimalarial,Drugs, Antimalarial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine
D015224 Dideoxynucleosides Nucleosides that have two hydroxy groups removed from the sugar moiety. The majority of these compounds have broad-spectrum antiretroviral activity due to their action as antimetabolites. The nucleosides are phosphorylated intracellularly to their 5'-triphosphates and act as chain-terminating inhibitors of viral reverse transcription. 2',3'-Dideoxynucleosides,Dideoxyribonucleosides,ddNus,2',3' Dideoxynucleosides
D016778 Malaria, Falciparum Malaria caused by PLASMODIUM FALCIPARUM. This is the severest form of malaria and is associated with the highest levels of parasites in the blood. This disease is characterized by irregularly recurring febrile paroxysms that in extreme cases occur with acute cerebral, renal, or gastrointestinal manifestations. Plasmodium falciparum Malaria,Malaria, Plasmodium falciparum

Related Publications

Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
January 2003, Nucleic acids research. Supplement (2001),
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
January 2000, Nucleic acids symposium series,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
September 2012, Parasitology international,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
January 2001, Nucleosides, nucleotides & nucleic acids,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
September 2016, Organic letters,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
August 2006, Bioorganic & medicinal chemistry,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
July 1995, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
March 1999, Bioorganic & medicinal chemistry letters,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
January 2005, Nucleosides, nucleotides & nucleic acids,
Yoshihiro Noguchi, and Yuri Yasuda, and Makoto Tashiro, and Tadashi Kataoka, and Yoshiaki Kitamura, and Mahmoud Kandeel, and Yukio Kitade
June 2008, Archives of pharmacal research,
Copied contents to your clipboard!